Omnipod® for children
We understand that caring for a child with type 1 diabetes isn’t easy. You want an insulin delivery method that can meet your child’s evolving health needs, while also granting them the freedom of being a child.
Omnipod works with you and your little one to do just that. With no multiple daily injections and no tubes, Pod Therapy is insulin pump therapy, simplified.
In a survey, 97% of Omnipod® users in the US said that they would recommend it to a friend
The benefits of Omnipod
Freedom to play, freedom to learn, freedom to be a child!
No multiple daily injections, and no tubes: Each tubeless, wearable Pod delivers insulin for up to three days (72 hours). Your child can go to a dance class or play video games with fewer interruptions.
Waterproof†: The Pod can be worn while swimming, bathing, or showering.
Discreet: Small enough to be worn under clothing, with no tubes hanging loose.
Accurate: Precise dosing with 0.05 unit increments gives you greater control around mealtimes.
All of this could mean less diabetes disruption for your family, greater peace of mind for you - and more independence for your little one.
How does the Omnipod work?
Pod Therapy from Omnipod is a tubeless insulin delivery system designed for people with type 1 diabetes ages 2 years and older.
Pod Therapy replaces the need for multiple daily injections by delivering small, customisable doses of insulin to your child’s body steadily throughout the day, through a wearable and waterproof† patch pump called a Pod.
Omnipod differs from other insulin pump products with its innovative, compact, and tubeless design, made to fit around you and your child’s busy lives.
Meet our Tubeless, wearable Omnipod® Lineup.
Omnipod 5 Automated Insulin Delivery System
Omnipod 5 is the first and only tubeless automated insulin delivery system that works with the leading sensor brands*.
Compatible with the Dexcom G6 sensor and the FreeStyle Libre 2 Plus sensor, Omnipod 5 makes automated basal insulin adjustments every five minutes to help keep your child in range1,2.
Omnipod DASH® Insulin Management System
Simplify Life™ with Omnipod DASH. Place the Pod on your child’s body almost anywhere you would inject insulin for up to three days (72 hours) of precise, continuous insulin delivery.
Discreetly and conveniently adjust your child’s insulin doses with a few finger taps wherever you are‡, without any insulin pump tubing.
Don’t let the terminology hold you back!
There’s never been a better time to embrace diabetes technology with Omnipod, but the terminology can be confusing.
Pod University is our library of resources that cuts through the jargon. You can learn about different diabetes devices at your own pace, and explore the potential benefits for your child.
Try a Sample Pod§ At Home Today!
The Pod Experience Kit* contains a real-size, real-weight demo Pod*, without the insulin.
It’s designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.
Talk to an Omnipod® Specialist
Still have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat. Or you can call us direct at 0800 011 6132* (option 4) or +44 20 3887 1709 (option 4) if calling from abroad.
Try the Omnipod 5 Simulator App
Try a simulated version of the Omnipod 5 Controller for yourself with the Omnipod 5 Simulator App.
The demo screens are just like the real Controller‡, giving you an overview of just how simple the system is to use. They’re a great tool for the virtual demo, too!
* Requires Dexcom G6 or FreeStyle Libre 2 Plus sensor. Bolus for meals and corrections are still needed.
‡At start-up, the Pod and Controller / Personal Diabetes Manager must be adjacent and touching. During normal operation, the Personal Diabetes Manager must be within 1.5 metres of the Pod.
1. Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%.
2. Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (>180mg/dL) from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose (<70mg/dL) from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%. Sherr JL, et al. Diabetes Care (2022).